These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15171896)

  • 1. [The severe acute respiratory syndrome].
    Madariaga MG; Gotuzzo E
    Rev Clin Esp; 2004 Jun; 204(6):323-5. PubMed ID: 15171896
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe acute respiratory syndrome treatment: present status and future strategy.
    Lau AC; So LK
    Curr Opin Investig Drugs; 2003 Aug; 4(8):918-20. PubMed ID: 14508874
    [No Abstract]   [Full Text] [Related]  

  • 3. [Emergency treatment for Middle Eastern coronaviruses (MERS-CoV].
    Nau JY
    Rev Med Suisse; 2013 Jun; 9(392):1394-5. PubMed ID: 23882919
    [No Abstract]   [Full Text] [Related]  

  • 4. Ribavirin in the treatment of severe acute respiratory syndrome (SARS).
    van Vonderen MG; Bos JC; Prins JM; Wertheim-van Dillen P; Speelman P
    Neth J Med; 2003 Jul; 61(7):238-41. PubMed ID: 14567520
    [No Abstract]   [Full Text] [Related]  

  • 5. Ribavarin should be tested in clinical trials in combination with other antiviral agents for severe acute respiratory syndrome.
    Chu CM; Chan KS
    Chest; 2005 Dec; 128(6):4050. PubMed ID: 16354884
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacotherapy of severe acute respiratory syndrome (SARS)].
    von Hagen L; Pletz MW; Dickgreber N; Golpon H; Bauer TT; Zabel P; Welte T; Groneberg DA
    Pneumologie; 2006 Nov; 60(11):694-700. PubMed ID: 17109267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The war against an unknown pathogen: rising to the SARS challenge.
    Can Commun Dis Rep; 2003 May; 29(9):77-82. PubMed ID: 12739275
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials and novel pathogens: lessons learned from SARS.
    Muller MP; McGeer A; Straus SE; Hawryluck L; Gold WL
    Emerg Infect Dis; 2004 Mar; 10(3):389-94. PubMed ID: 15109402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of antiviral and anti-inflammatory treatment for severe acute respiratory syndrome.
    Chihrin S; Loutfy MR
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):251-62. PubMed ID: 15918782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and pharmacotherapy of severe acute respiratory syndrome: what have we learnt?
    Tsang KW; Ooi GC; Ho PL
    Eur Respir J; 2004 Dec; 24(6):1025-32. PubMed ID: 15572549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral agents and corticosteroids in the treatment of severe acute respiratory syndrome (SARS).
    Yu WC; Hui DS; Chan-Yeung M
    Thorax; 2004 Aug; 59(8):643-5. PubMed ID: 15282381
    [No Abstract]   [Full Text] [Related]  

  • 12. Pro/con clinical debate: steroids are a key component in the treatment of SARS. Con: No, steroids are not a key component of the treatment regimen for SARS.
    Kargel MJ; Lapinsky SE
    Crit Care; 2004 Apr; 8(2):105-7. PubMed ID: 15515216
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe acute respiratory syndrome: Relapse? Hospital infection?
    Tsang OT; Chau TN; Choi KW; Tso EY; Lim W; Chiu MC; Tong WL; Lee PO; Lam BH; Ng TK; Lai JY; Yu WC; Lai ST
    Emerg Infect Dis; 2003 Sep; 9(9):1180-1. PubMed ID: 14531379
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential for receptor-based antiviral drugs against SARS.
    Williams RK; Yeager CL; Holmes KV
    Lancet; 2003 Jul; 362(9377):77. PubMed ID: 12853208
    [No Abstract]   [Full Text] [Related]  

  • 15. 18th International Conference on Antiviral Research. Respiratory viruses.
    Kibble A
    IDrugs; 2005 Jun; 8(6):465-6. PubMed ID: 15906188
    [No Abstract]   [Full Text] [Related]  

  • 16. On interferon research.
    Hou YD
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):205-6. PubMed ID: 16267893
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute respiratory distress syndrome in a child with human parvovirus B19 infection.
    Ferraz C; Cunha F; Mota TC; Carvalho JM; Simões JS; Aparicio JM
    Pediatr Infect Dis J; 2005 Nov; 24(11):1009-10. PubMed ID: 16282940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of corticosteroids in SARS.
    Oba Y
    N Engl J Med; 2003 May; 348(20):2034-5; author reply 2034-5. PubMed ID: 12748321
    [No Abstract]   [Full Text] [Related]  

  • 19. Ribavirin trials and hantavirus--what we should not conclude.
    Marcus KA; Johann-Liang R; Powers JH
    Clin Infect Dis; 2005 May; 40(10):1550-1. PubMed ID: 15844085
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiviral treatment of SARS: can we draw any conclusions?
    Zhaori G
    CMAJ; 2003 Nov; 169(11):1165-6. PubMed ID: 14638651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.